1 World Health Organization (WHO) (2009) UNAIDS Towards universal access - Scaling up priority HIV/AIDS interventions in the health sector (progress report 2009),Geneve, Switzerland.
2Dembélé M, Saleri N, Carvalho AC, Saouadogo T, Hien AD, et al. [2010] Incidence of tuberculosis after HAART initiation in a cohort of HIV-positive patients in Burkina Faso.Int J Tuberc Lung Dis 14:318-323.
3Muula AS, Ngulube TJ, Siziya S, Makupe CM, Umar E, et al. (2007)Gender distribution of adult patients on highly active antiretroviral therapy (HAART) in Southern Africa: a systematic review.BMC Public Health 7:63.
4UNAIDS Global AIDS Epidemic Update(2011). Geneva, Switzerland.
5Federal Ministry of Health (FMOH) (2010) National HIV sero- prevalence Senntinnel Survey. Abuja: Federal ministry of health.
6National Agency for the Control of AIDS (NACA) (2011) Fact sheet Women, girls and HIV in Nigeria.
7Odutolu O, Ahonsi B, Gboun M, Jolayemi , Adeyi O, et al. (2006) Response to HIV/AIDS in Nigeria: OlusojiAdeyi (1stedn) A Nation on the Threshold. Massachusetts Harvard University Press, USA.
8Moatti JP, Spire B (2003)Economic and socio-behavioural issues related to highly active antiretroviral therapies for HIV infection: the contribution of social science research. Med Sci19: 878-884.
9Rao D, Kekwaletswe TC, Hosek S, Martinez J, Rodriguez F (2007) Stigma and social barriers to medication adherence with urban youth living with HIV. AIDS Care 19:28-33.
10Tapper ML, Flexner C, Eron JJ, Molina JM (2004) Simplifying antiretroviral therapy. AIDS Read 14:355-360, 367-371.
11McPherson-Baker S, Jones D, Durán RE, Klimas N, Schneiderman N (2005) Development and implementation of a medication adherence training instrument for persons living with HIV: the MATI. BehavModif29:286-317.
12Amico KR, Toro-Alfonso J, Fisher JD (2005) An empirical test of the information, motivation and behavioral skills model of antiretroviral therapy adherence. AIDS Care 17:661-673.
13Remien RH, Bastos FI, Jnr VT, Raxach JC, Pinto RM, et al. (2007) Adherence to antiretroviral therapy in a context of universal access, in Rio de Janeiro, Brazil. AIDS Care 19:740-748.
14Weiser S, Wolfe W, Bangsberg D, Thior I, Gilbert P (2003) Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana.J Acquir Immune DeficSyndr34:281-288.
15Weiss L, French T, Finkelstein R, Waters M, Mukherjee R (2003) HIV-related knowledge and adherence to HAART. AIDS Care 15:673-679.
16Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN (2000) Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med.133:21-30.
17Nilsson Schönnesson L, Diamond PM, Ross MW, Williams M, Bratt G (2006) Baseline predictors of three types of antiretroviral therapy (ART) adherence: A 2-year follow-up. AIDS Care18:246-253.
18Poppa A, Davidson O, Deutsch J, Godfrey D, Fisher M, et al. (2004)British HIV Association (BHIVA)/British Association for Sexual Health and HIV (BASHH) guidelines on provision of adherence support to individuals receiving antiretroviral therapy (2003). HIV Med 5:46-60.
19Cornell M, Myer L, Kaplan R, Bekker LG, Wood R (2009) The impact of gender and income on survival and retention in a South African antiretroviral therapy programme. Trop Med Int Health 14:722-731.
20Kempf MC, Pisu M, Dumcheva A, Westfall AO, Kilby JM (2009) Gender differences in discontinuation of antiretroviral treatment regimens. J Acquir Immune DeficSyndr52:336-341.
21Merenstein D, Schneider MF, Cox C, Schwartz R, Weber K, et al. (2009) Association of child care burden and household composition with adherence to highly active antiretroviral therapy in the Women's Interagency HIV Study. AIDS Patient Care STDS 23:289-29
22Vyavaharkar M, Moneyham L, Tavakoli A, Phillips KD, Murdaugh C, et al. (2007) Social support, coping, and medication adherence among HIV-positive women with depression living in rural areas of the southeastern United States.AIDS Patient Care STDS 21:667-680.
23Murray LK, Semrau K, McCurley E, Thea DM, Scott N, et al. (2009)Barriers to acceptance and adherence of antiretroviral therapy in urban Zambian women: a qualitative study. AIDS Care 21:78-86.
24Svarstad BL, Chewning BA, Sleath BL, Claesson C (1998)The brief medication questionnaire: A tool for screening patient adherence and barriers to adherence. Patient EducCouns37:113–124.
25Olowookere SA, Fatiregun AA, Akinyemi JO, Bamgboye AE, Osagbemi GK (2008) Prevalence and determinants of nonadherence to highly active antiretroviral therapy among people living with HIV/AIDS in Ibadan, Nigeria. J Infect DevCtries2:369-372.
26Hogg R, Heath K, Bangsberg D, Yip B, Press N, et al.(2002)Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up. AIDS Care 16:51-58.
27Oku AO, Owoaje ET, Ige OK, Oyo-Ita A (2013) Prevalence and determinants of adherence to HAART amongst PLHIV in a tertiary health facility in south-south Nigeria. BMC Infect Dis 13:401.
28Shaahu VN, Lawoyin TO, Sangowawa AO (2008) Adherence to highly active antiretroviral therapy (HAAT) at a Federal Medical Centre. Afr J Med Sci 37: 29-36.
29Agu KA, Okojie O, Oqua D, King RC, Omonaiye O, et al. (2011) Medication Adherence and Risk factors for Non-adherence among Patients taking Highly Active Antiretroviral Therapy. West African Journal of Pharmacy 22:19-26.
30Iliyasu Z, Kabir M, Abubakar IS, Babashani M, Zubair ZA (2005) Compliance to antiretroviral therapy among AIDS patients in Aminu Kano Teaching Hospital, Kano, Nigeria. Niger J Med 14:290-294.
31NwaucheC, Erhabor O, Ejele O, Akani C (2006) Adherence to Antiretroviral therapy among HIV-infected subjects in a resourcelimited setting in the Niger Delta of Nigeria. Afr J Health Sci 13:13 -17.
32Talam NC, Gatongi P, Rotich J, Kimaiyo S (2008) Factors affecting antiretroviral drug adherence among HIV/AIDS adult patients attending HIV/AIDS clinic at Moi Teaching and Referral Hospital, Eldoret, Kenya.East Afr J Public Health 5:74-78.
33El-Khatib Z, Ekstrom AM, Coovadia A, Abrams EJ, Petzold M, et al. (2011) Adherence and virologic suppression during the first 24 weeks on antiretroviral therapy among women in Johannesburg, South Africa - a prospective cohort study. BMC Public Health 11:88.
34Musiime S, Muhairwe F, Rutagengwa A, Mutimura E, Anastos K,( 2011) Adherence to highly active antiretroviral treatment in HIV-infected Rwandan women.PLoS One 6:1-6.
35Amberbir A, Woldemichael K, Getachew S, Girma B, Deribe K (2008)Predictors of adherence to antiretroviral therapy among HIV-infected persons: a prospective study in Southwest Ethiopia. BMC Public Health 8:1-10.
36Wakibi SN, Ng'ang'a ZW, Mbugua GG (2011) Factors associated with non-adherence to highly active antiretroviral therapy in Nairobi, Kenya. AIDS Res Ther43:1-8.
37 Endrias M, Alemayebu W, Gail D (2008) Adherence to HAART in PLWHA at Yirgalem Hospital South Ethopia. Ethopian Journal of health Development22:174-179.
38Falang KD, Akubaka N, Jimam NS(2012) Patient Factors impacting Antiretroviral drug adherence in a Nigerian tertiary Hospital. Journal of Pharmacology and Pharmacotherapeutics3:138-142.
39Sow PG, Toure K, Coume M, Dia AT, Traore I (2012) Predictors of ART adherence among HIV infected individuals in Dakar, Senegal. Journal of Medicine and Medical Science 3:212-216.
40 Chesney M (2003) Adherence to HAART regimens. AIDS Patient Care STDS 17:169-177.
41Afolabi MO, Ijadunola KT, Fatusi AO, Olasode OA (2009)Determinants of adherence to antiretroviral drugs among people living with HIV/AIDS in the Ife-Ijesa zone of Osun state, Nigeria. Afr J Prm Health Care Fam Med1:6.
42Sarna A, Luchters S, Geibel S, Munyao P, Kaai S et al.( 2005) Promoting adherence to antiretroviral therapy through a directly administered antiretroviral therapy (DAART) strategy in Mombasa, Kenya. Population Council.
43Malcolm SE, Ng JJ, Rosen RK, Stone VE (2003) An examination of HIV/AIDS patients who have excellent adherence to HAART. AIDS Care 15:251-261.
44Chesney M (1997) New antiretroviral therapies: Adherence challenges and strategies. Presented at the Adherence in HIV Therapy: Implication for Nursing practice, San Francisco, USA.
45Gordillo V, del Amo J, Soriano V, González-Lahoz J (1999) Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS13:1763-1769.
46Ekama SO, Herbertson EC, Addeh EJ, Gab-Okafor CV, Onwujekwe DI, et al. (2012) Pattern and determinants of antiretroviral drug adherence among Nigerian pregnant women. J Pregnancy 2012:1-6.